| http://www.w3.org/ns/prov#value | - Dr. Kenneth Offit, chief of the clinical genetics service at Memorial Sloan-Kettering Cancer Center, noted that many academic labs are planning to offer panel tests for up to hundreds of genes for the cost of Myriad???s test for two genes.??? Myriad plans to phase out the current BRCA test in 2015 and replace it with a test that examines 25 genes that contribute to breast and other types of cancer
|
